Leading organisations call for hepatitis C services to be decentralised


  • Mary Corcoran
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

Four societies focused on liver disease research and treatment have announced a global call-to-action initiative to simplify hepatitis C (HCV) testing and treatment.

The European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Diseases (AASLD), the Asian-Pacific Association for the Study of the Liver (APASL) and the Latin American Association for the Study of the Liver (ALEH) have collaborated with the Clinton Health Access Initiative (CHAI) to develop strategies to address barriers to achieving HCV elimination. 

They have identified four key clinical strategies which they say can be used as part of continuing HCV elimination efforts, including simplifying diagnostic and treatment algorithms, integrating HCV treatment with primary care and other disease programmes, decentralising HCV services to local level care, and task-sharing care with primary care clinicians and other healthcare practitioners.

The call to action document also highlights the efficacy of existing screening and treatments, including accurate rapid HCV antibody screening and confirmatory viral load testing which can be accomplished in a single clinical visit, in addition to pan-genotypic direct-acting antivirals (DAAs) that are available in fixed-dose combinations with efficacy rates greater than 95 per cent and minimal side effects.